St. Martin De Porress Hospital Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2020
NCT04619082
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Emergency Medicine Department of St. Martin De Porres Hospital | St. Martin De Porress Hospital

Active Ingredients

Drugs in Phase 4 Trials (1)

tenofovir alafenamide (genvoya) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Hepatitis B (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 1